Footprint- and xeno-free human iPSCs derived from urine cells using extracellular matrix-based culture conditions

Biomaterials

Volumn 35, Issue 29, 2014, Pages 8330-8338

  Lee, Kang In ^a   Kim, Hyeong Taek ^a   Hwang, Dong Youn ^a  

^a CHA University   (South Korea)

Author keywords

Cell therapy; Induced pluripotent stem cells; Integration free; Urine cells; Xeno free

Indexed keywords

BODY FLUIDS; CELL DEATH; STEM CELLS;

ADIPOSE-DERIVED STROMAL CELLS; CELL THERAPY; CLINICAL APPLICATION; CULTURE CONDITIONS; CULTURE MEDIUM; INDUCED PLURIPOTENT STEM CELLS; INTEGRATION-FREE; XENO-FREE;

MOLECULAR BIOLOGY;

DNA METHYLTRANSFERASE 3B; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOSE DERIVED STEM CELL; ADULT; ANALYTICAL PARAMETERS; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL THERAPY; DNA FINGERPRINTING; EXTRACELLULAR MATRIX; FOOTPRINT PLURIPOTENT STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOMATIC CELL; SUBSTITUTION THERAPY; URINALYSIS; XENO FREE PLURIPOTENT STEM CELL; XENO-FREE CULTURE; ADIPOSE TISSUE; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; PROCEDURES; URINE;

ADIPOSE TISSUE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EXTRACELLULAR MATRIX; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TRANSFECTION; URINE;

EID: 84904123505     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.059     Document Type: Article

References (28)

1. Jia F., Wilson K.D., Sun N., Gupta D.M., Huang M., Li Z., et al. Anonviral minicircle vector for deriving human iPS cells. Nat Meth 2010, 7:197-199.
2. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, Ny) 2009, 324:797-801.
3. Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., et al. Amore efficient method to generate integration-free human iPS cells. Nat Meth 2011, 8:409-412.
4. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
5. Fusaki N., Ban H., Nishiyama A., Saeki K., Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on sendai virus, an RNA virus that does not integrate into the host genome. proceedings of the Japan academy series B. Phys Biol Sci 2009, 85:348-362.
6. Martin M.J., Muotri A., Gage F., Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005, 11:228-232.
7. Heiskanen A., Satomaa T., Tiitinen S., Laitinen A., Mannelin S., Impola U., et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells (Dayt Ohio) 2007, 25:197-202.
8. Hu W., Yan Q., Fang Y., Qiu Z., Zhang S. Generation of human induced pluripotent stem cells with non-integrating episomal vectors and xeno-free culture system. JAnim Veterinary Adv 2013, 12:1114-1122.
9. Nakagawa M., Taniguchi Y., Senda S., Takizawa N., Ichisaka T., Asano K., et al. Anovel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 2014, 4:3594.
10. Fukusumi H., Shofuda T., Kanematsu D., Yamamoto A., Suemizu H., Nakamura M., et al. Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells. PloS One 2013, 8:e55226.
11. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
12. Takenaka C., Nishishita N., Takada N., Jakt L.M., Kawamata S. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol 2010, 38:154-162.
13. Haase A., Olmer R., Schwanke K., Wunderlich S., Merkert S., Hess C., et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009, 5:434-441.
14. Giorgetti A., Montserrat N., Aasen T., Gonzalez F., Rodriguez-Piza I., Vassena R., et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009, 5:353-357.
15. Loh Y.H., Hartung O., Li H., Guo C., Sahalie J.M., Manos P.D., et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010, 7:15-19.
16. Staerk J., Dawlaty M.M., Gao Q., Maetzel D., Hanna J., Sommer C.A., et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010, 7:20-24.
17. Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010, 7:11-14.
18. Sun N., Panetta N.J., Gupta D.M., Wilson K.D., Lee A., Jia F., et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 2009, 106:15720-15725.
19. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
20. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008, 26:1276-1284.
21. Zhou T., Benda C., Duzinger S., Huang Y., Li X., Li Y., et al. Generation of induced pluripotent stem cells from urine. JAm Soc Nephrol: JASN 2011, 22:1221-1228.
22. Kim H.T., Lee K.I., Kim D.W., Hwang D.Y. An ECM-based culture system for the generation and maintenance of xeno-free human iPS cells. Biomaterials 2013, 34:1041-1050.
23. Jeon E.S., Moon H.J., Lee M.J., Song H.Y., Kim Y.M., Cho M., et al. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells (Dayt Ohio) 2008, 26:789-797.
24. Muller F.J., Schuldt B.M., Williams R., Mason D., Altun G., Papapetrou E.P., et al. Abioinformatic assay for pluripotency in human cells. Nat Meth 2011, 8:315-317.
25. Benda C., Zhou T., Wang X., Tian W., Grillari J., Tse H.F., et al. Urine as a source of stem cells. Adv Biochem Eng Biotechnol 2013, 129:19-32.
26. Xu Y., Wei X., Wang M., Zhang R., Fu Y., Xing M., et al. Proliferation rate of somatic cells affects reprogramming efficiency. JBiol Chem 2013, 288:9767-9778.
27. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
28. Wernig M., Meissner A., Cassady J.P., Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008, 2:10-12.